Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early intervention for adult metabolic syndrome in the Beijing region
ChiCTR-TRC-08000099Phase 4Completed
- Sponsor
- China-Japan Friendship Hospital
- Start
- Jun 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of metformin and pioglitazone in cardiometabolic risk (CMR) (3 arms), sponsored by China-Japan Friendship Hospital. Primary endpoints: Changes of common carotid artery intima-media thickness and Incidence of diabetes. Started Jun 2008; status: completed.
02
Drugs
metforminpioglitazone
03
Conditions
cardiometabolic risk (CMR)
Beyond the preview
Go deeper on ChiCTR-TRC-08000099.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-08000099.